Communication of survival data in US Food and Drug Administration-approved labeling of cancer drugs
Naci, H.
, Guan, X., Woloshin, S., Xu, Z. & Wagner, A. K.
(2021).
Communication of survival data in US Food and Drug Administration-approved labeling of cancer drugs.
JAMA Internal Medicine,
181(11), 1521 - 1522.
https://doi.org/10.1001/jamainternmed.2021.3505
| Item Type | Article |
|---|---|
| Copyright holders | © 2021 American Medical Association |
| Departments | LSE > Academic Departments > Health Policy |
| DOI | 10.1001/jamainternmed.2021.3505 |
| Date Deposited | 23 Apr 2024 |
| Acceptance Date | 17 May 2021 |
| URI | https://researchonline.lse.ac.uk/id/eprint/122738 |
Explore Further
- https://www.scopus.com/pages/publications/85109893855 (Scopus publication)
- https://www.lse.ac.uk/health-policy/people/huseyin-naci-phd-mhs (Author)
- https://jamanetwork.com/journals/jamainternalmedic... (Official URL)
ORCID: https://orcid.org/0000-0002-7192-5751